ASHLEY HRABIK: Open Payments
NPI 1750741112 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$334 in 16 payments from 9 companies in 2025. Trend: 2023 $296 · 2024 $454 · 2025 $334
Food & beverage: $334
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $70 |
| Novartis Pharmaceuticals Corporation | 2 | $51 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $48 |
| Janssen Biotech, Inc. | 2 | $40 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 2 | $30 |
| LEO Pharma Inc. | 1 | $24 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
Products named: SKYRIZI, COSENTYX, TREMFYA, SPEVIGO, Sotyktu, Odomzo, BLU-U, ADBRY.
Industry payments across MO — which companies pay providers there.
